SCHEMBL2779608

SCHEMBL2779608

C[C]1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777396 0.90
SCHEMBL2251501 0.75
SCHEMBL11720970 0.67 CRBN (0.50)
SCHEMBL22755787 0.66 FKBP5 (0.37)
SCHEMBL8096949 0.65
SCHEMBL1236722 0.65 FKBP5 (0.42)
SCHEMBL434844 0.63
SCHEMBL10070969 0.63
SCHEMBL22252125 0.63
SCHEMBL28507164 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056522-A1 INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT SANTEN PHARMACEUTICAL CO., LTD. (JP) 2010-03-04 US claimed
EP-0002236-A1 Peptides, their salts, their acid addition salts, pharmaceutical formulations containing them and their use as morphine antagonists and anaesthetics THE WELLCOME FOUNDATION LIMITED (GB) 1979-06-13 EP claimed
EP-2539317-A2 DIHYDROLIPOIC ACID DERIVATIVES COMPRISING NITRIC OXIDE AND THERAPEUTIC USES THEREOF Invasc Therapeutics, Inc. (US) 2013-01-02 EP disclosed
EP-2265611-A1 TRICYCLIC DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. (IT) 2010-12-29 EP disclosed
WO-2010096677-A2 DIHYDROLIPOIC ACID DERIVATIVES COMPRISING NITRIC OXIDE AND THERAPEUTIC USES THEREOF INVASC THERAPEUTICS, INC. (US) 2010-08-26 WO disclosed
WO-2010045575-A2 COMPOSITIONS AND METHODS FOR TREATMENT OF RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM (RAAS)-RELATED DISORDERS INVASC THERAPEUTICS, INC. (US) 2010-04-22 WO disclosed
US-20100056522-A1 INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITOR EFFECT AS ACTIVE INGREDIENT SANTEN PHARMACEUTICAL CO., LTD. (JP) 2010-03-04 US disclosed
WO-2009112832-A1 TRICYCLIC DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2009-09-17 WO disclosed
EP-1768955-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2007-04-04 EP disclosed
WO-2006005941-A1 AMIDE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) 2006-01-19 WO disclosed
US-4363800-A PEPTIDES USEFUL AS ANTITUSSIVES AND AS ANTI-DIARRHDEALS BURROUGHS WELLCOME CO. (US) 1982-12-14 US disclosed
US-4362717-A ANTITUSSIVE AGENTS BURROUGHS WELLCOME CO. (US) 1982-12-07 US disclosed
US-4346083-A ANTIDIARRHEAL AND ANTITUSSIVE OLIGOPEPTIDES BURROUGHS WELLCOME CO. (US) 1982-08-24 US disclosed
US-4343795-A OLIGOPEPTIDES; ANTIDIARRHEA, ANTITUSSIVE BURROUGHS WELLCOME CO. (US) 1982-08-10 US disclosed
US-4244944-A OLIGOPEPTIDE OF TYROSINE, METHIONINE (OPTIONALLY OXIDIZED), GLYCINE, NITROPHENYLALANINE, PROLINAMIDE BURROUGHS WELLCOME CO. (US) 1981-01-13 US disclosed
EP-0002236-A1 Peptides, their salts, their acid addition salts, pharmaceutical formulations containing them and their use as morphine antagonists and anaesthetics THE WELLCOME FOUNDATION LIMITED (GB) 1979-06-13 EP disclosed
US-3988321-A PREEMERGENCE HERBICIDES MONSANTO COMPANY (US) 1976-10-26 US disclosed
US-3984383-A HEAT AGING RESISTANCE, SCORCH RESISTANCE BRIDGESTONE TIRE COMPANY LIMITED (JA) 1976-10-05 US disclosed
US-3969407-A Substituted carbamoyl sulfines and their manufacture MONSANTO COMPANY (US) 1976-07-13 US disclosed
US-3959330-A HERBICIDE MONSANTO COMPANY (US) 1976-05-25 US disclosed